DOI QR코드

DOI QR Code

Reinfection by Opisthorchis Viverrini after Treatment with Praziquantel

  • Published : 2016.03.07

Abstract

Background: The prevalence of infection by the liver fluke, Opisthorchis viverrini (O. viverrini), has remained high in Northeast Thailand where it is a major risk factor for the eventual development of cholangiocarcinoma (CCA). The infection is acquired by the consumption of dishes containing unsafely prepared freshwater fish, a dietary tradition which has proved resistant to change. Since many people are aware that dosing with praziquantel (PZQ) is a successful treatment for an episode of the infection, there is a risk that, to avoid the long term consequences, they will engage in a cycle of infection, dosing and reinfection. Objectives: There is a dearth of studies of reinfection by O. viverrini, and the aims of this study were to assess re-infection rates in a typical province of Northeastern Thailand where O. viverrini infection is likely and to investigate factors associated with reinfection. Materials and Methods: A total of infected 607 villagers were treated with PZQ, and those found to be no longer infected were followed up at six-monthly intervals over 12 months. Results: At the end of this period data on 457 subjects were available for analysis using descriptive statistics and logistic regression, and 50 were found to have become reinfected, giving a cumulative reinfection rate of 10.9%. The results of a multiple logistic regression analysis showed that the only factor found to be associated with reinfection was past use of PZQ. Conclusions: Recommendations are made for future larger scale and better designed reinfection studies in the light of limitations of the current study. Further efforts are needed to discourage people from eating fish dishes likely to contain viable metacariae.

Keywords

References

  1. Aunpromma S, Tangkawattana P, Papirom P, et al (2012). High prevalence of Opisthorchis viverrini infection in reservoir hosts in four districts of Khon Kaen Province, an opisthorchiasis endemic area of Thailand. Parasitol Int, 61, 60-4 https://doi.org/10.1016/j.parint.2011.08.004
  2. Boonmars T, Srirach P, Kaewsamut B, et al (2008). Apoptosisrelated gene expression in hamster opisthorchiasis post praziquantel treatment. Parasitol Res, 102, 447-55 https://doi.org/10.1007/s00436-007-0783-5
  3. Chernrungroj G (2000). Risk factors for cholangiocarcinoma:a case-control study. Yale University, New Haven, Connecticut.
  4. Grundy-Warr C, Andrews RH, Sithithaworn P, et al (2012). Raw attitudes, wetland cultures, life-styles: Socio-cultural dynamics relating to Opisthorchis viverrini in the Mekong basin. Parasitol Int, 61, 65-70. https://doi.org/10.1016/j.parint.2011.06.015
  5. IARC. Schistosomes, liver flukes and Helicobacterpylori (1994). IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monogr Eval Carcinog Risks Hum, 61, 1-241.
  6. IARC. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2012). Biological agents. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum, 100, 1-441.
  7. Kamsa-ard S, Laopaiboon M, Bhudhisawasdi V (2013). Association between Praziquantel and Cholangiocarcinoma in Patients Infected with Opisthorchis viverrini: A Systematic Review and Meta-Analysis. Asian Pacific J Cancer Prev, 14, 7011-6. https://doi.org/10.7314/APJCP.2013.14.11.7011
  8. Kamsa-ard S, Luvira V, Pugkhem A, et al (2015). Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control study. BMC Cancer, 15, 776. https://doi.org/10.1186/s12885-015-1788-6
  9. Khuhaprema T, Srivatanakul P, Attasara P, et al (2010). Cancer in Thailand 2001-2003. vol.V. Bangkok Medical Publisher, Bangkok.
  10. Lovis L, Mak TK, Phongluxa K, et al (2009). PCR diagnosis of Opisthorchis viverrini and Haplorchis taichui infections in a Lao community in an area of endemicity and comparison of diagnostic methods for parasitological field surveys. J Clin Microbiol, 47, 1517-23. https://doi.org/10.1128/JCM.02011-08
  11. Lovis L, Mak TK, Phongluxa K, et al. (2012). Efficacy of praziquantel against Schistosoma mekongi and Opisthorchis viverrini: a randomized, single-blinded dose-comparison trial. PLoS Negl Trop Dis, 6, 1726. https://doi.org/10.1371/journal.pntd.0001726
  12. Miwa M, Honjo S, You G, et al (2014). Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand. World J Gastrointest Pathophysiol, 15, 570-8.
  13. Pinlaor S, Ma N, Hiraku Y, et al (2004). Repeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7,8-dihydro-2'-deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase. Carcinogenesis, 25, 1535-52. https://doi.org/10.1093/carcin/bgh157
  14. Poomphakwaen K, Promthet S, Kamsa-ard S, et al (2009). Risk factors for cholangiocarcinoma in Khon Kaen, Thailand: a nested case-control study. Asian Pac J Cancer Prev, 10, 251-7.
  15. Prasongwatana J, Laummaaunwai P, Boonmars P, Pinloar S (2013). Viable metacercariae of Opisthorchis viverrini in northeastern Thai cyprinid dishes - as part of a rational program for control of O. viverrini-associated cholangiocarcinoma. Parasitol Res, 112, 1323-7. https://doi.org/10.1007/s00436-012-3154-9
  16. Pungpak S, Chalermrut K, Harinasuta T, et al (1994) Opisthorchis viverrini infection in Thailand: symptoms and signs of infection - apopulation-based study. Trans R Soc Trop Med Hyg, 88, 561-4 https://doi.org/10.1016/0035-9203(94)90164-3
  17. Saengsawang P, Promthet S, Bradshaw P (2012). Prevalence of OV infection in Yasothon Province, Northeast Thailand. Asian Pac J Cancer Prev, 13, 3399-402. https://doi.org/10.7314/APJCP.2012.13.7.3399
  18. Sayasone S, Utzinger J, Akkhavong K, Odermatt P (2015). Repeated stool sampling and use of multiple techniques enhance the sensitivity of helminth diagnosis: A crosssectional survey in southern Lao People's Democratic Republic. Acta Tropica, 141, 315-21. https://doi.org/10.1016/j.actatropica.2014.09.004
  19. Sithithaworn P, Tesana S, Pipitgool V, et al (1991). Relationship between faecal egg count and worm burden of Opisthorchis viverrini in human autopsy cases. Parasitol, 102, 277-81. https://doi.org/10.1017/S0031182000062594
  20. Sithithaworn P, Andrews RH, Nguyen VD, et al (2012). The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. Parasitol Int, 61, 10-6. https://doi.org/10.1016/j.parint.2011.08.014
  21. Sithithaworn P, Yongvanit P, Duenngai K, Kiatsopit K, Pairojkul C (2014). Roles of liver fluke infection as risk factor for cholangiocarcinoma. J Hepatobiliary Pancreat Sci, 21, 301-8. https://doi.org/10.1002/jhbp.62
  22. Songserm N, Promthet S, Sithithaworn P, et al (2012). Risk factors for cholangiocarcinoma in high-risk area of Thailand:role of lifestyle, diet and methylenetetrahydrofolate reductase polymorphisms. Cancer Epidemiol, 36, 89-94. https://doi.org/10.1016/j.canep.2011.04.005
  23. Sornmani S, Vivatanasesth P, Impand P, et al (1984). Infection and reinfection rates of opisthorchiasis in the water resource development area of Nam Pong project, Khon Kaen Province, northeast Thailand. Ann Trop Med Parasitol, 78, 649-56. https://doi.org/10.1080/00034983.1984.11811877
  24. Sripa B, Kaewkes S, Sithithaworn P, et al (2007). Liver fluke induces cholangiocarcinoma. PLoS Med, 4, 201. https://doi.org/10.1371/journal.pmed.0040201
  25. Sripa B, Pairojkul C (2008). Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol, 24, 349-56. https://doi.org/10.1097/MOG.0b013e3282fbf9b3
  26. Sripa B, Bethony JM, Sithithaworn B, et al (2011). Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Tropica, 120, 158-68. https://doi.org/10.1016/j.actatropica.2010.07.006
  27. Sripa B, Tangkawattan T, Laha L, et al (2015). Toward integrated opisthorchiasis control in northeast Thailand: The Lawa project. Acta Tropica, 141, 361-7. https://doi.org/10.1016/j.actatropica.2014.07.017
  28. Sudsarn P, Boonmars T, Ruangjirachuporn W, et al (2015). Combination of praziquantel and aspirin minimizes liver pathology of hamster Opisthorchis viverrini infection associated cholangiocarcinoma. Pathol Oncol Res, 15, 9967.
  29. Upatham ES, Viyanant V, Brockelman WY, et al (1988). Rate of re-infection by Opisthorchis viverrini in an endemic northeast Thai community after chemotherapy. Int J Parasitol, 18, 643-9. https://doi.org/10.1016/0020-7519(88)90099-9
  30. Watanapa P, Watanapa W (2002). Liver fluke-associated cholangiocarcinoma. Br J Surg, 89, 962-70. https://doi.org/10.1046/j.1365-2168.2002.02143.x
  31. Wongpa N, Thaewnongiew K, Phathee K (2011). Liver fluke infection and control in the Northeast of Thailand through action research. Asian Pac J Cancer Prev, 12, 1367-70
  32. Worasith C, Kamamia C, Yakovleva A, et al (2015). Advances in the diagnosis of human opisthorchiasis: development of opisthorchis viverrini antigen detection in Urine. PLoS Negl Trop Dis, 9, 4157.
  33. World Health Organization (1991). Basic laboratory methods in medical parasitology. WHO, Geneva, 25-28.

Cited by

  1. Health Behavior Regarding Liver Flukes among Rural People in Nakhon Ratchasima, Thailand vol.17, pp.4, 2016, https://doi.org/10.7314/APJCP.2016.17.4.2111
  2. Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention vol.110, pp.1, 2017, https://doi.org/10.1007/s13149-017-0544-8
  3. Structural Analysis of an Epitope Candidate of Triosephosphate Isomerase in Opisthorchis viverrini vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-33479-8
  4. Mothers’ Opisthorchis viverrini infection status and raw fish dish consumption in Lao People’s Democratic Republic: determinants of child infection status vol.46, pp.1, 2018, https://doi.org/10.1186/s41182-018-0112-y